» Articles » PMID: 9555725

Engineering Passive Immunity in Transgenic Mice Secreting Virus-neutralizing Antibodies in Milk

Overview
Journal Nat Biotechnol
Specialty Biotechnology
Date 1998 Apr 29
PMID 9555725
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Protection against enteric infections can be provided by the oral administration of pathogen-neutralizing antibodies. To provide passive immunity, 18 lines of transgenic mice secreting a recombinant monoclonal antibody (Mab) neutralizing transmissible gastroenteritis coronavirus (TGEV) into the milk were generated. The genes encoding a chimeric Mab with the variable modules of the murine TGEV-specific Mab 6A.C3 and the constant modules of a human IgG, isotype Mab were expressed under the control of regulatory sequences derived from the whey acidic protein, which is an abundant milk protein. The Mab 6A.C3 binds to a highly conserved epitope present in coronaviruses of several species, which does not allow the selection of neutralization escape mutants. Antibody expression titers of 10(6) were obtained in the milk of transgenic mice that reduced TGEV infectivity 10(6)-fold. The antibody was synthesized at high levels throughout lactation. Integration of matrix attachment region sequences with the antibody genes led to a 20- to 10,000-fold increase in the antibody titer in 50% of the transgenic animals. Antibody expression levels were transgene copy number independent and related to the site of integration. The generation of transgenic animals producing virus neutralizing antibodies in milk could provide an approach to protection against neonatal infections of the enteric tract.

Citing Articles

Anti-SARS-CoV-2-specific antibodies in human breast milk following SARS-CoV-2 infection during pregnancy: a prospective cohort study.

Fernandez-Buhigas I, Rayo N, Silos J, Serrano B, Ocon-Hernandez O, Leung B Int Breastfeed J. 2024; 19(1):5.

PMID: 38238855 PMC: 10797875. DOI: 10.1186/s13006-023-00605-w.


A Comprehensive Analysis of Maternal and Newborn Disease and Related Control for COVID-19.

Cimolai N SN Compr Clin Med. 2021; 3(6):1272-1294.

PMID: 33754135 PMC: 7968576. DOI: 10.1007/s42399-021-00836-0.


Applying Immune Instincts and Maternal Intelligence from Comparative Microbiology to COVID-19.

Cimolai N SN Compr Clin Med. 2020; 2(12):2670-2683.

PMID: 33195997 PMC: 7652409. DOI: 10.1007/s42399-020-00634-0.


Expression of recombinant antibodies.

Frenzel A, Hust M, Schirrmann T Front Immunol. 2013; 4:217.

PMID: 23908655 PMC: 3725456. DOI: 10.3389/fimmu.2013.00217.


Use of transgenic animals in biotechnology: prospects and problems.

Maksimenko O, Deykin A, Khodarovich Y, Georgiev P Acta Naturae. 2013; 5(1):33-46.

PMID: 23556129 PMC: 3612824.


References
1.
Castilla J, Sola I, Enjuanes L . Interference of coronavirus infection by expression of immunoglobulin G (IgG) or IgA virus-neutralizing antibodies. J Virol. 1997; 71(7):5251-8. PMC: 191761. DOI: 10.1128/JVI.71.7.5251-5258.1997. View

2.
McKnight R, Spencer M, Wall R, Hennighausen L . Severe position effects imposed on a 1 kb mouse whey acidic protein gene promoter are overcome by heterologous matrix attachment regions. Mol Reprod Dev. 1996; 44(2):179-84. DOI: 10.1002/(SICI)1098-2795(199606)44:2<179::AID-MRD6>3.0.CO;2-K. View

3.
Gebauer F, Posthumus W, Correa I, Sune C, Smerdou C, Sanchez C . Residues involved in the antigenic sites of transmissible gastroenteritis coronavirus S glycoprotein. Virology. 1991; 183(1):225-38. PMC: 7130809. DOI: 10.1016/0042-6822(91)90135-x. View

4.
Anton I, Sune C, Meloen R, Borras-Cuesta F, Enjuanes L . A transmissible gastroenteritis coronavirus nucleoprotein epitope elicits T helper cells that collaborate in the in vitro antibody synthesis to the three major structural viral proteins. Virology. 1995; 212(2):746-51. PMC: 7131354. DOI: 10.1006/viro.1995.1535. View

5.
Poljak L, Seum C, Mattioni T, Laemmli U . SARs stimulate but do not confer position independent gene expression. Nucleic Acids Res. 1994; 22(21):4386-94. PMC: 308471. DOI: 10.1093/nar/22.21.4386. View